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Abstract 
Objectives: The Test of Masticating and Swallowing Solids (TOMASS) has been proposed 
as a quantifiable assessment of swallowing efficiency that encompasses both oral and 
pharyngeal components of swallowing. This test may have clinical application as a dysphagia 
screening and treatment outcome measure. Reduced swallowing efficiency has been 
documented in patients with Parkinson’s disease (PD). The literature also suggests that 
severity of PD motor symptoms correlates with dysphagia severity. This study aimed to 
determine whether the TOMASS is a sensitive tool for identifying a decline in swallowing 
efficiency related to the presence and severity of PD. Comparison of performance on the 
TOMASS with a test that had already been validated in this population, the 150 ml Timed 
Water Swallowing Test (TWST), might also provide further insight in to the sensitivity of the 
TOMASS, it’s relationship with dysphagia, and application to the PD population. 
 
Participants: Forty participants with a diagnosis of PD were evenly recruited to two groups 
based on severity of PD motor symptoms: mild-moderate PD and advanced PD. 
Classification was based on Hoehn and Yahr scale PD severity scores that were assigned to 
PD participants after administration of the Movement Disorders Society – Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS) part III – motor examination. Age and 
gender-matched controls for each group were also recruited. 
 
Method: Each participant completed the Eating Assessment Tool (EAT-10) survey. 
Participants then completed two trials of a 150 ml TWST and two trials of the TOMASS 
whilst being video recorded. The order in which these tests were presented was counter-
balanced. Total time taken, number of bites, number of masticatory cycles, and number of 
swallows were recorded for solid food trials. Total time taken, number of swallows, and 
volume swallowed were recorded for fluid trials. To establish intra- and inter-rater reliability, 
20% of the video-recordings were randomly selected and reviewed by the primary researcher 
and two final-year speech-language therapy (SLT) students. 
  
Results: High intra-rater reliability (ICC > 0.8) was achieved across all measures on the 
TOMASS and the TWST. Similarly, high inter-rater reliability (ICC > 0.8) was achieved 
across all measures on TWST and TOMASS except the number of swallows on the 
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TOMASS, which had only moderate agreement (ICC=0.67). There were no significant 
differences in TOMASS measures between the mild-moderate PD and advanced PD groups. 
There was, however, a longer total time required for the mild-moderate PD group compared 
to the control group and a longer total time and an increased number of swallows, 
masticatory cycles, and bites in the advanced PD group compared to the control group on the 
TOMASS. There was a positive correlation between increasing PD severity as indicated by 
higher MDS-UPDRS scores and masticatory cycles. Positive correlations were found 
between TOMASS and TWST for total time and number of swallows. 
 
Conclusions:  The TOMASS is a sensitive measure of reduced solid food swallowing 
efficiency caused by PD. The presence of PD rather than severity appears to have a stronger 
influence on reduced swallowing efficiency but PD severity does appear to play a role. 
Despite the differences in TOMASS variables between groups, the effect sizes were small, 
which reduces its clinical applicability. However, the sample of patients recruited in this 
study did not represent the severity of patients clinically presenting for swallowing evaluation 
and population bias can explain these small effect sizes. The number of masticatory cycles 
appears to be the most sensitive measure in response to changes to PD severity but it is 
unclear what impact dentition has on this measure. The TOMASS is a solid food correlate to 
the TWST, as expected, and there is a relationship between decreased efficiency in 
completing the TOMASS and the presence of dysphagia. Further research to validate the 
TOMASS is required before conclusions can be drawn around its clinical application. 
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Chapter 1. Introduction 
Assessment of swallowing function is necessary in adult populations at high risk of 
swallowing impairment to facilitate treatment planning and reduced associated illness and 
morbidity. Impairment in swallowing function, known as dysphagia, occurs in over 68% of 
individuals with Parkinson’s disease (PD) (Coelho et al., 2010; Kalf, de Swart, Bloem, & 
Munneke, 2012). The presence and severity of dysphagia increases as PD severity increases 
(Kalf et al., 2011; Umemoto, Tsuboi, Kitashima, Furuya, & Kikuta, 2011) and patient report 
is not a sensitive measure of identifying the presence of dysphagia in the PD population (Kalf 
et al., 2012; Manor, Giladi, Cohen, Fliss, & Cohen, 2007). Reduced swallowing efficiency in 
the PD population has been reported (Kanna & Bhanu, 2014; Miller et al., 2009) with 
reduced swallowing speed associated with increased risk of developing aspiration pneumonia 
(Lin et al., 2012). Although both the oral and pharyngeal phases of swallowing are impacted 
by PD (Baijens et al., 2011; Nagaya, Kachi, & Yamada, 2000), oral phase dysphagia may be 
more prevalent in the PD population than pharyngeal phase dysphagia (Lam et al., 2007). 
 
Clinical swallowing examinations (CSE) conducted by speech and language therapists are 
primarily subjective, resulting in insufficient reliability (McCullough et al., 2000) and 
reduced sensitivity and specificity in diagnosing dysphagia (Splaingard, Hutchins, Sulton, & 
Chaudhuri, 1988). Increasing the objectivity of the CSE with more quantifiable assessment 
measures can improve the reliability of this assessment. 
 
A timed water swallowing test (TWST) has been established as a reliable quantifiable clinical 
swallowing assessment (Nathadwarawala, Nicklin, & Wiles, 1992) that is sensitive to 
changes in swallowing function resulting from Parkinson’s disease (Miller et al., 2009) and 
other neurological disorders (Hughes & Wiles, 1996). A similar timed test of solid food 
swallowing, the Test of Masticating and Swallowing Solids (TOMASS), was developed by 
Athukorala, Jones, Sella, and Huckabee (2014), because water swallowing may be less 
sensitive to oral phase swallowing impairments and cannot assess aspects of solid food 
ingestion such as mastication. Limited research has been published on the TOMASS 
(Athukorala et al., 2014; Battel & Huckabee, 2014a, 2014b; Huckabee, McIntosh, & 
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Apperley, 2014) and further investigation into the reliability and sensitivity of the TOMASS 
in the context of dysphagia and specific patient populations is required for validation. 
 
This study has been designed to investigate the sensitivity of the TOMASS in response to 
swallowing impairment associated with PD and increasing PD severity. Additionally, this 
study has been designed to determine the extent to which the TOMASS is a solid-food 
swallowing correlate to the TWST. Therefore the following research questions are addressed: 
1. Is the TOMASS a sensitive assessment tool for detecting reduced swallowing 
efficiency that may result from the presence of PD? 
2. Is the TOMASS a sensitive assessment tool for detecting reduced swallowing 
efficiency that may result from increased severity of PD motor symptoms?  
3. Will participant performance on the TOMASS correlate with performance on the 
TWST, with performance on both tests decreasing as PD severity increases? 
 
Information on the reliability of the TOMASS and the relationship between the TOMASS 
and TWST performance has been gained through the design of this study.  
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Chapter 2. Literature review 
2.1 Swallowing  
Swallowing is often conceptualised as consisting of three phases: oral, pharyngeal, and 
oesophageal. However, for ingestive swallowing, this process begins with a pre-oral phase 
even before the bolus touches the lips. This pre-oral phase of swallowing involves cortical 
processing of a bolus, based in part on sensory information received from the olfactory and 
optic cranial nerves, to develop an appropriate swallowing plan. The three primary phases of 
swallowing and the swallowing biomechanics of each are described in further detail in the 
following sub-sections.  
 
2.1.1 Oral phase 
The oral phase of swallowing is largely voluntary and involves coordinated labial opening 
and closure, mastication and lingual movements to receive, maintain, and manipulate the 
bolus in the oral cavity.  The trigeminal, facial, and hypoglossal nerves, the pharyngeal 
plexus (components of the glossopharyngeal and vagus nerves), and ansa cervicalis (cervical 
spinal nerves 1 and 2) are involved in motor aspects of these movements. Sensory feedback 
during this phase is provided through the trigeminal, facial, and glossopharyngeal nerves 
(Jean, 2001). 
 
Mastication involves rapid and regular jaw motion with distinct open and close cycles. 
Movement of the jaw also results in hyoid movement. A general trend of the hyoid retracting 
downward as the jaw closes has been documented (Palmer, Rudin, Lara, & Crompton, 1992). 
 
On completion of mastication and oral preparation of a solid bolus, a specific sequence of 
movements has been observed to facilitate transfer of the bolus into the pharynx. The hyoid 
moves posteriorly and inferiorly as the jaw closes. After the hyoid and jaw reach this 
retracted position, the back of the tongue which was raised to meet the palate, now drops 
allowing space for bolus entry into the pharynx. The hyoid and tongue then move sharply 
upward and forward while the tongue compresses the bolus against the palate (Palmer et al., 
1992). As the jaw opens slowly, tongue to palate contact reaches peak pressure (Hori, Ono, & 
Nokubi, 2006) and the tongue progresses backward, squeezing food back along the palate and 
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into the oropharynx. Rotational movement of the tongue occurs during this bolus transfer, 
with prolonged tongue to palatal contact on the non-masticatory side (Hori et al., 2006).  
 
Transfer of larger solid boluses from the oral cavity to the pharynx can be segmented. Several 
transfer cycles may occur during mastication and oral preparation prior to the bulk of the 
bolus being transferred and the initiation of a swallow. Mastication continues and appears 
largely uninterrupted by segmented bolus transfer. Anterior displacement of the hyoid is 
greater during swallowing than during chewing or bolus transfer. Swallowing onset occurs in 
the closed phase of a masticatory cycle (Palmer et al., 1992).  
 
Differences in food textures have been found to result in differences in time required to orally 
prepare food for swallowing, time between the bolus entering the pharynx and swallow onset, 
and time taken between swallows. Liquid ingestion requires minimal oral preparatory time 
with prompt swallowing onset on transfer into the pharynx, allowing for a more rapid and 
reflexive swallowing plan (Palmer et al., 1992). Oral preparatory time tends to increase with 
increasing density of solid foods (Palmer et al., 1992) and a longer swallowing duration also 
occurs with denser boluses (Cassiani, Santos, Parreira, & Dantas, 2011; Palmer et al., 1992).  
 
2.1.2 Pharyngeal phase 
The pharyngeal phase begins with the onset of swallowing. This usually occurs on active 
transfer of the bolus from the mouth into the pharynx. When a pharyngeal swallow is 
triggered, the mylohyoid muscle in the floor of mouth is the first muscle to become active 
(Jean, 2001). A rapid sequential but overlapping activation and relaxation of the muscle pairs 
involved in pharyngeal swallowing follows. Consequently, the following is achieved:  
• anterior hyoid movement which in turn assists with epiglottic deflection and upper 
oesophageal sphincter (UES) opening 
• velopharyngeal closure 
• supraglottic shortening 
• vocal fold adduction 
• base of tongue to posterior pharyngeal wall contact  
• pharyngeal shortening 
• sequential contraction of the pharyngeal muscles superiorly to inferiorly squeezing 
the bolus through the open UES  
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• UES contraction on completion of the swallow as the hyoid returns to rest.  
 
The trigeminal, facial, vagus, and glossopharyngeal nerves, as well as the pharyngeal plexus 
and ansa cervicalis, are all involved in these motor processes. Sensory input to allow for 
airway protection and clearance is provided through the pharyngeal plexus and superior 
laryngeal nerve of the vagus or the recurrent laryngeal nerve at the carina (Jean, 2001). 
 
2.1.3 Oesophageal phase 
The oesophageal phase begins once the bolus has passed through the upper oesophageal 
sphincter. The bolus is then transferred in a peristaltic wave (Jean, 2001). Completion of the 
pharyngeal and oesophageal phases of swallowing occurs within 0.6 to 1.0 s (Jean, 2001). 
 
2.2 Dysphagia Assessment 
Considering the complex, precise, and rapid nature of swallowing, it is not surprising that 
swallowing can become impaired. Impairment in swallowing is known as dysphagia. 
Although dysphagia can present overtly through coughing, choking, or discomfort when 
eating and drinking, an individual may not be aware of the presence of dysphagia. 
Impairment to sensation and/or cognition can result in reduced awareness. If sensory input is 
reduced then airway protection mechanisms, such as reflexive coughing, may not be 
triggered in response to the entry of food and/or fluids into the airway.  This is known as 
silent aspiration. Aspiration can result in serious health consequences such as pneumonia. 
Aspiration pneumonia presents a leading cause of infection or death and is associated with 
many neurological illnesses (Fernandez & Lapane, 2002). Swallowing assessment in 
populations considered to be at high-risk of developing dysphagia is required in order to 
avoid serious health and psychosocial consequences and apply appropriate management 
strategies.  
 
Dysphagia is initially, and at times solely, assessed using a subjective clinical swallowing 
examination (CSE) involving a medical file review, case history, oral motor examination, and 
oral trials of a range of bolus textures and viscosities. A CSE is used to determine the risk of  
dysphagia and need for instrumental swallowing assessment, such as videofluoroscopic 
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swallowing studies (VFSS) and video-endoscopic evaluation of swallowing (VEES) are 
appropriate.  
 
Instrumental assessments of swallowing such as VFSS and VEES are considered to be ‘gold 
standards’ for assessment of swallowing function as they allow for visualisation of 
swallowing physiology and bolus flow as well as identification of silent aspiration (Wu, 
Chang, Wang, & Lin, 2004). As these assessments can be expensive and invasive to perform, 
it is not feasible or appropriate to perform these assessments on every patient suspected of, or 
at risk of, dysphagia. Consequently, CSE is the only method used for identification of 
dysphagia in many patients. The subjective nature of the CSE presents an issue relating to 
inter- and intra-rater reliability.  
  
Reliability of performing this assessment is important because the CSE is the basis for further 
management of dysphagia. McCullough et al. (2000) investigated the inter- and intra-rater 
reliability of the components of the CSE. Three experienced speech-language therapists 
(SLTs) used the CSE to assess the swallowing of twenty patients who were six-weeks post-
stroke. Assessment of each patient was performed twice across two consecutive days. The 
SLTs assessed in pairs, with one of the three SLT’s assessing the same patient twice and the 
other two assessing this patient only once. Adequate inter- and intra-rater reliability was 
found in 28% of the history measures, 58% of the oral motor measures, 60% of the voice 
measures, and 15% of the swallowing measures. Overall, inter- and intra-rater reliability for 
CSE was 44%. This well-designed study, conducted by experienced clinicians, revealed that 
inter- and even intra-rater reliability of the CSE is unsatisfactory. 
 
Splaingard et al. (1988) investigated the validity of the CSE for detecting aspiration in 107 
rehabilitation patients by comparing the CSE findings to those of VFSS. They found that 
40% of the patients aspirated on VFSS and silent aspiration was observed in half of these 
patients. Only 42% of the patients found to aspirate on VFSS were identified through CSE, 
with some of these patients having been categorised to be within normal limits through CSE. 
Only three of the ten patients found by VFSS to have profound dysphagia were identified as 
such based on CSE and two of these had not been determined to aspirate at all. The authors of 
this study approached analysis of the CSE by breaking it into a five-point severity scale and 
also did not control for level of clinical experience, which may have negatively impacted on 
the sensitivity of the CSE.  
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These results indicate that the reliability and validity of CSE is generally insufficient. The 
oral trial component of the CSE was found to be the least reliable component of the CSE 
(McCullough et al., 2000). The subjective nature of the oral trials component of the CSE  
likely contributes to poor reliability. Therefore, more objective quantifiable measures for 
assessing swallowing would be of considerable value.  
  
2.2.1 Adjuncts to the clinical swallowing examination 
A number of adjuncts to the CSE have been introduced over the years in an attempt to 
increase the reliability and validity of this assessment. The following discussion focuses on 
those adjuncts that relate specifically to the oral trial component of the CSE. 
2.2.1.1 Cervical auscultation 
Cervical auscultation allows for assessment of the sounds of swallowing and swallowing-
related respiration with amplification of these sounds provided through a stethoscope. This 
technique has shown some merit in offering information to clinicians regarding the presence 
or absence of dysphagia and aspiration during swallowing trials (Bergstrom, Svensson, & 
Hartelius, 2013; Borr, Hielscher-Fastabend, & Lucking, 2007; Leslie, Drinnan, Finn, Ford, & 
Wilson, 2004; Stroud, Lawrie, & Wiles, 2002; Zenner, Losinski, & Mills, 1995) and may 
assist in the sensitivity or specificity of the oral trial component of the CSE. However, this 
technique is highly subjective and reliant on the individual’s level of skill and training in this 
technique and, hence, suffers from the same subjective criticisms as the CSE itself.  Even 
professionals trained in this technique are highly variable in their interpretation of the same 
swallowing sounds (Borr et al., 2007; Leslie et al., 2004; Stroud et al., 2002) and often over-
identified elderly swallows as being dysphagic (Borr et al., 2007). Although there are two or 
three distinct sounds related to oral pharyngeal swallowing, the physiologic or bolus-related 
causes of these sounds remain unclear, with a high degree of inconsistency among non-
dysphagic swallowers reported (Leslie et al., 2007; Spadotto et al., 2012).  
2.2.1.2 Pulse Oximetry 
Pulse oximetry measures arterial blood oxygenation.  When paired with oral trials, it has been 
employed as an adjunct to the CSE to potentially detect aspiration. One theory behind this 
application, is that reflexive bronchoconstriction occurs in response to aspiration resulting in 
a drop in blood oxygenation (Bergstrom et al., 2013). This technique provides quantitative 
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information regarding blood oxygenation changes but the link between blood oxygenation 
and swallowing or aspiration is unclear. As safe swallowing requires a period of apnea, a 
drop in oxygen saturation during this task may reflect the individual’s tolerance of 
interruptions to their respiration rather than aspiration or dysphagia. Reduced oxygen 
saturation was found to have a greater association with the presence of a respiratory illness or 
neurological disorder rather than the occurrence of aspiration (Colodny, 2001). Early studies 
investigating the use of this technique paired with oral trials reported that pulse oximetry had 
a high sensitivity and specificity in detecting aspiration (Collins & Bakheit, 1997; Lim et al., 
2001). A later study with a stronger design found that a drop in oxygen saturation had a low 
sensitivity and specificity in detecting aspiration (Wang, Chang, Chen, & Hsiao, 2005). This 
finding was supported by further research by Ramsey, Smithard, and Kalra (2006) who 
paired pulse oximetry with a modified CSE. They found neither a drop in oxygen saturation 
alone nor paired with the CSE was adequate to identify aspiration risk as later determined by 
VFSS.  Although potentially offering an objective measure to the CSE, the relationship 
between swallowing and oxygen saturation remains unclear and is therefore of limited value 
for increasing the reliability or validity of the CSE. 
2.2.1.3 Water swallowing tests 
A 3-oz water swallowing test (WST) was introduced by DePippo, Holas, and Reding (1992). 
Patients were asked to drink 90 ml of water from a cup without interruption. It was 
hypothesised that a larger standardised volume of fluid would be more likely to elicit a cough 
response than previous fluid trials used in the CSE and would, therefore, be more sensitive to 
identifying aspiration. The sensitivity and specificity of this test in identifying aspiration has 
been investigated by comparing outcomes with VFSS (DePippo et al., 1992) or VEES 
(Leder, Suiter, & Green, 2011; Suiter & Leder, 2008). Reported sensitivity of this test ranges 
from 76% (DePippo et al., 1992) to 100% (Leder et al., 2011) but specificity is low. The 
studies reporting the highest sensitivity contained a number of limitations including failure to 
employ any blinding methods between VEES examination and water swallow trials with the 
VEES administered prior to the WST. The examiners therefore knew if a patient aspirated 
before administering the aspiration screening test. The criteria used to determine a fail on the 
WST included cough, wet voice, and an inability to complete the test, allowing a large 
amount of subjectivity in determining pass or fail. There was also no measure of inter-rater 
reliability employed (Leder et al., 2011; Suiter & Leder, 2008). 
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A blinded study comparing water swallowing tests and VEES found that the perception of 
‘wet voice’ is not a reliable indicator of aspiration or penetration (Warms & Richards, 2000). 
Wu et al. (2004) found that coughing, choking, and post-swallow wet-hoarse voice, was a 
poor clinical predictor of dysphagia, with a sensitivity of 47.8% in a 100 ml water swallow 
test, particularly failing to detect silent aspirators. Miles and Huckabee (2013) found that 
interpretation of the presence or absence of a cough is subjective resulting in only fair inter-
rater reliability. Water swallowing tests, therefore, when applied for the purpose of 
identification of aspiration, have conflicting validity and lack quantifiable measures required 
for adequate reliability.   
2.2.1.4 Timed water swallowing tests 
A timed component to the WST has also been introduced, allowing for increased objectivity 
and a quantifiable measure of swallowing efficiency. There are several derivatives of a timed 
water swallow test (TWST). Nathadwarawala et al. (1992) investigated the reliability and 
validity of a 150 ml TWST. High inter- and intra-rater reliability and consistency in an 
individual’s performance from one trial to the next, even when variations in flavour and 
temperature were introduced was reported. However, reliability data for timing of this test 
was established on very small numbers of healthy subjects. Normative data for swallowing 
speed was established using 101 healthy subjects. A dysphagia questionnaire was used to 
determine the presence or absence of a perceived swallowing problem in 81 individuals with 
a neurological impairment. A slow swallowing speed (<10 ml/s) was found to have a 
sensitivity of 96% and specificity of 69% in identifying the presence of perceived dysphagia.  
 
 Hughes and Wiles (1996) assessed swallowing efficiency using another derivative of a 
TWST in 181 healthy controls aged between 18 to 91 years and in 30 patients with motor 
neuron disease. They compared the impact of age, sex, height, and neurological impairment 
on average bolus volume, average time per swallow, and swallowing capacity (ml/s). A 
clearly defined procedure for this assessment was outlined, allowing for this test to be 
reliably repeated by both clinicians and researchers. A number of bolus volumes were 
presented, including 150 ml, for which normative data were gained. Those with motor neuron 
disease who reported the presence of dysphagia displayed reduced swallowing efficiency 
compared to those who did not report dysphagia and the controls. Differences in average 
swallowing capacity were observed across age, gender, and height with greater swallowing 
capacity documented in younger age, males, and increased height. 
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Wu et al. (2004) validated a 100 ml TWST against VFSS in 59 patients suspected of having 
dysphagia. Reduced swallowing speed on the TWST had a high sensitivity but reduced 
specificity as an indicator of dysphagia as determined by VFSS. The presence of coughing or 
choking during this TWST had high specificity but reduced sensitivity in detecting 
penetration or aspiration. When results of this TWST were combined with the presence of 
choking, a sensitivity of 85.5% and specificity of 91.7% for identifying the presence of 
dysphagia using the 100 ml TWST was reported. 
 
With the introduction of objective measures to oral fluid trials in the form of a TWST, the 
reliability and validity of the CSE increased. However, this test offers limited information 
about the oral phase of swallowing and the CSE would also benefit from an objective 
measurement of swallowing solid foods. 
2.3 Test of Masticating and Swallowing Solids (TOMASS) 
The TOMASS was developed as a solid bolus swallowing correlate to the TWST by Hughes 
and Wiles (1996). The TOMASS allows a quantifiable measure that is inclusive of the oral 
preparatory phase of swallowing which is not challenged by fluid swallowing tests. Patients 
are asked to eat a single Salada™ cracker ‘as quickly as is comfortably possible’ and to 
indicate they have finished by stating their name. The number of bites, masticatory cycles, 
and swallows and the total time taken to complete this task are recorded.  Analyses are 
conducted on both this raw data and derived measures of masticatory cycles per bite, 
swallows per bite, time per bite, time per masticatory cycle, and time per swallow.  
 
Normative data on the TOMASS were established by Huckabee, McIntosh, Fuller, and Curry 
(2015) in 84 healthy adults, evenly distributed by sex across four age groups ranging from 20 
years to over 80 years. Each participant performed two TOMASS trials. As the Salada™ 
cracker is not commercially available worldwide, a further normative sample of 80 
participants was established for the Nabisco Saltine™ cracker. Both crackers are almost 
identical in size, weight, and ingredients but comparisons between TOMASS performance 
revealed differences between cracker groups in all raw data and calculated measures, with the 
exception of number of bites and time per swallow. As a trial effect was identified, the first 
trial was used for all analyses as this would be the most clinically feasible application. This 
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study indicated that normative data would be required for each variation of TOMASS cracker 
used. Age and sex differences were found for all raw data measures across both cracker 
types. Reduced efficiency on all TOMASS raw data measures with increasing age was seen 
in both normative samples. Increasing age was associated with both increased time and an 
increase in biomechanical movements in completing the TOMASS.  Males displayed greater 
efficiency than age equivalent females with fewer bites, chews, and swallows as well as a 
shorter time taken to complete the TOMASS as reflected by the all raw data measures.  
 
A further sample of 40 healthy adults was later recruited to establish test-retest and inter-rater 
reliability data for the TOMASS (Huckabee et al., 2015). The Salada™ cracker was used in 
this study.  Participants completed two TOMASS trials three times across three consecutive 
days. Two raters were present during one of these three sessions and each rater independently 
collected the four raw data TOMASS measures. Participants were offered a sip of water 
between TOMASS trials to eliminate any dry mouth or oral residual that may have resulted 
from the first TOMASS. Despite this, a within-session trial effect was still observed with 
more masticatory cycles, swallows, and a longer total time seen across the second trial. Inter-
rater reliability was almost perfect (ICC > 0.98) for all measures and test-retest reliability 
across sessions was also high with ICC values ranging from 0.83 to 0.98.  
 
The strong reliability data now established for the TOMASS reinforces the objective nature 
of this assessment and the normative data available for the TOMASS thus far presents a 
normal range to compare patient performance to during clinical use. However, validation of 
the TOMASS is required to ensure that the TOMASS is a sensitive measure of changes in 
swallowing efficiency and the presence of dysphagia. Use of the TOMASS during the CSE 
would increase reliability if the TOMASS is found to be a valid dysphagia assessment tool. 
 
A preliminary TOMASS validation study was completed by Apperley, McIntosh, and 
Huckabee (2015) to assess whether the TOMASS is sensitive to changes in oral function. The 
TOMASS was completed by 10 healthy adults prior to, immediately after, and one hour after 
application of a topical oral anaesthetic gel. A standardised amount of oral anaesthetic was 
applied to the tongue blade using a syringe and distributed around the oral cavity by 
participants. Differences in the raw data TOMASS variables of masticatory cycles and total 
time as well as the derived measures relating to these variables were observed between the 
baseline and oral anaesthesia conditions. These differences had resolved within one hour after 
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anesthesia.  
 
Findings from the validation study indicates that the TOMASS is sensitive to changes in oral 
function and may be a sensitive dysphagia assessment tool. However, further research into 
the sensitivity of the TOMASS to impairment in specific populations is indicated for 
establishing validity. The present study is one of a number of studies designed to investigate 
the sensitivity of the TOMASS for use within the Parkinson’s disease (PD) population. 
2.4 Parkinson’s disease 
PD is a chronic, progressive, neurological disorder of the central nervous system. An 
estimated prevalence rate for PD is 1% of the population over 60 years old (Snow & 
Macdonald, 2013). Studies of similar design report incidence rates of 16 to 19 PD cases per 
100,000 individuals per year (Caslake et al., 2013; Twelves, Perkins, & Counsell, 2003). 
Primary symptoms of PD include tremor, rigidity, bradykinesia (slowness of initiation of 
voluntary movement with progressive reduction in speed and amplitude of repetitive actions), 
and postural instability (Hughes, Daniel, Kilford, & Lees, 1992). These symptoms largely 
impact on mobility. However, PD can also impact other functions such as speech, swallowing 
and cognition. PD presents differently between individuals, with differing degrees and areas 
of motor and neurological impairment. PD can be difficult to diagnose as symptoms of 
Parkinsonism are not always caused by PD (Snow & Macdonald, 2013). 
 
2.4.1 Neurological basis of Parkinson’s disease 
Lewy bodies and/or Lewy nutrites, created by a build up of alpha-synuclein protein, are clear 
biological indicators of the presence of PD on autopsy and differentiate PD from other 
progressive neurological disorders (Mu et al., 2013), although some individuals who 
clinically present with PD do not display these markers (Berg et al., 2014). These Lewy 
bodies and Lewy nutrites, which cause neuronal death, identify which structures are affected 
as part of the disease process (Mu et al., 2013) and the nature of disease progression (Braak et 
al., 2003). The first signs of PD are found to appear in the brainstem, with a gradual 
progression through the midbrain and eventually in the cortical areas (Braak et al., 2003).  
PD is often not symptomatic until the disease has progressed beyond the midbrain (Braak, 
Ghebremedhin, Rub, Bratzke, & Del Tredici, 2004). This may be due to increased effect on 
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the substantia nigra, which produces the neurotransmitter dopamine. When the neurons 
containing this neurotransmitter die, tremor, rigidity, bradykinesia, postural instability, and 
other motor impairments characteristic of PD occur.  
 
2.5 Parkinson’s disease and dysphagia 
2.5.1 Prevalence of dysphagia in Parkinson’s disease 
There are mixed reports relating to the prevalence of dysphagia in PD. Kalf et al. (2012) 
conducted a meta-analysis of studies looking at the prevalence of dysphagia in people living 
in community-based dwellings with PD. Oral-pharyngeal dysphagia was found to be present 
in at least one third of this population and an individual with PD was three times more likely 
to have oral-pharyngeal dysphagia than a healthy age-matched control (Kalf et al., 2012). 
This figure was also reflected in a questionnaire-based study of 75 PD participants conducted 
by Walker, Dunn, and Gray (2011). Dysphagia prevalence rates increase as disease severity 
increases (Kalf et al., 2011; Kalf et al., 2012; Lam et al., 2007; Umemoto et al., 2011; Walker 
et al., 2011). Prevalence of dysphagia in PD is likely to be higher than reported as 
institutionalised individuals with a higher degree of dependence or disability were not 
included in the studies reporting this rate.  
 
A questionnaire was provided to 50 individuals with late stage PD by Coelho et al. (2010) 
with 68% of respondents reporting symptoms of dysphagia. Prevalence rates may be even 
higher than this as Kalf et al. (2012) noted that reported prevalence appeared dependent on 
assessment technique, with dysphagia identified less frequently when individuals were 
required to self report, for instance through questionnaires, as opposed to dysphagia being 
identified through clinical or instrumental assessment (Kalf et al., 2012; Manor et al., 2007). 
This is reinforced by studies that document aspiration in individuals with PD who reported no 
dysphagic symptoms (Ali et al., 1996; Nagaya et al., 2000). 
 
2.5.2 Relationship between dysphagia and Parkinson’s disease severity 
There is a developing body of evidence linking the presence and severity of dysphagia with 
increased severity of PD. This relationship has been investigated through subjective and 
objective dysphagia assessment. 
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A prospective study of 45 participants with PD ranging from modified Hoehn and Yahr stage 
II to stage V was conducted by Lam et al. (2007) in order to determine clinical predictors of 
oral-pharyngeal dysphagia diagnosed by VFSS. Six participants were rated to have severe 
oral-pharyngeal dysphagia, defined by severely impaired oral bolus manipulation and 
transport or the presence of any aspiration. Four of these six participants had silent aspiration. 
Hoehn and Yahr severity was higher and body mass index lower in those participants found 
to have severe oral-pharyngeal dysphagia. There were no other differences in participant 
demographics between those with and without severe dysphagia. This finding was reinforced 
by Walker et al. (2011) who found that a strong correlation existed between severity of 
impairment of gross motor skills and the presence of dysphagia but no correlation between 
dysphagia and time since diagnosis, age, or gender. Self-reported difficulty in keeping food 
or drink in the mouth was also found by Lam et al. (2007) to be a predictor of severe 
dysphagia in this small sample size. A higher percentage of swallowing abnormalities found 
on VFSS in these participants occurred in the oral rather than pharyngeal stage of the 
swallow. Kalf et al. (2011) validated the Radbound Oral Motor inventory for Parkinson’s 
disease, a five point scale for self-rated difficulties with speech, swallowing and drooling in 
PD. Higher ratings of impairment in this scale corresponded with higher PD severity ratings 
on the Hoehn and Yahr scale and the UPDRS motor examination.  
 
The specific relationship between disease severity and oral-phase dysphagia severity has been 
objectively investigated by Umemoto et al. (2011). Disease severity was assessed using the 
Hoehn and Yahr scale and dysphagia was quantitatively assessed using VFSS with a gelatine 
cube bolus. Assessment was conducted on 30 patients with PD during the “on” phase of 
levodopa medication. Participants were recruited into two even groups: mild-moderate PD 
(Hoehn and Yahr stage II and III) and severe PD (Hoehn and Yahr stage IV and V). There 
was no difference in levodopa dose between groups. Results indicated that disease severity 
correlates with presence and degree of dysphagia, with longer oropharyngeal transit times, 
slowed speed of mandibular movement and reduced tongue pressure in the severe PD group 
compared to the mild-moderate PD group. No difference in speed of tongue movement was 
found between groups.  
 
Further objective assessment of swallowing and the relationship with PD severity was 
completed by Kanna and Bhanu (2014) who compared Hoehn and Yahr and UPDRS part III 
severity ratings with efficiency in completing a TWST. They reported correlations between 
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reduced efficiency in the derived water swallowing parameters in patients scoring more than 
30 in the UPDRS part III motor examination and those with Hoehn and Yahr stage III or 
higher. However, the distribution of participants within each severity rating is unclear and 
exact p-values are not provided. Additional relationships between reduced swallowing 
efficiency and disease duration of five or more years, and scores on the mini mental-state 
examination lower than 26 were also reported. 
 
2.5.3 Consequences of dysphagia in Parkinson’s disease 
One of the most serious consequences of dysphagia in PD is pneumonia. Pneumonia is the 
most common cause of death in nursing home residents with PD (Fernandez & Lapane, 
2002). The highest risk of death is specific to those diagnosed with aspiration pneumonia 
(Fernandez & Lapane, 2002). However, the presence of aspiration alone does not result in 
aspiration pneumonia. A number of contributing factors including dependency for feeding 
and poor oral hygiene have been identified (Langmore et al., 1998). Individuals with PD are 
likely to become more physically dependent and more dysphagic as the disease progresses, 
thus increasing their risk of developing aspiration pneumonia. 
 
Dysphagia can also result in other serious health consequences such as dehydration and 
malnutrition. Dehydration has been associated with the use of thickened fluids (Robbins et 
al., 2008), which is a compensatory strategy often employed in the management of dysphagia 
in the PD population (Logemann et al., 2008). Even without the use of thickened fluids, 
discomfort when drinking fluids due to coughing or choking and reduced efficiency in 
drinking may result in a reduction in fluid intake and consequently lead to dehydration.  
 
Malnutrition is an additional consequence that may relate to discomfort when eating and 
therefore, eating avoidance. Additionally, modified diets that are often put in place to 
alleviate discomfort and reduce choking risk, can impact on appetite and food enjoyment. 
Difficulties finding foods that can be safely eaten and are palatable is also a significant factor 
reported by people with PD (Leow, Huckabee, Anderson, & Beckert, 2010). Issues with 
mobility may impact on ability to prepare meals, and prolonged episodes of freezing may 
limit opportunities to eat. The increased movement due to PD symptoms such as dyskinesia, 
rigidity, disturbed sleep, and tremor, results in increased energy expenditure and a potential 
increased need for a higher daily caloric intake (Kistner, Lhommee, & Krack, 2014). As 
adequate nutrition is required to maintain muscle mass, malnutrition can result in further 
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physical decline. Recent studies investigating the prevalence of malnutrition in the 
community based PD population report approximately 15-20% of individuals with PD are 
malnourished or at risk of malnutrition (Sheard, Ash, Mellick, Silburn, & Kerr, 2013; Wang 
et al., 2010). 
 
In addition to physical health consequences, dysphagia in PD can have a psychosocial 
impact. PD has been associated with a reduction in quality of life (Leow et al., 2010; 
Plowman-Prine et al., 2009), particularly when depression and clinical fluctuations are 
present or in more advanced stages of the disease (Slawek, Derejko, & Lass, 2005). Leow et 
al. (2010) used the Swallowing-related Quality of Life survey (SWAL-QOL) to investigate 
the impact of dysphagia related to PD on quality of life. The SWAL-QOL is a comprehensive 
patient-based dysphagia-specific questionnaire requiring ratings of 44 items within the ten 
domains (McHorney et al., 2000; McHorney et al., 2002). Those with dysphagia had poorer 
quality of life in the SWAL-QOL domains of mental health and social participation (Leow et 
al., 2010).  
 
2.5.4 Clinical presentation of dysphagia in Parkinson’s disease 
A number of studies have reported on the presentation of oral pharyngeal dysphagia in PD. 
Some studies relied on clinically-based assessments, which lack objectivity, such as that used 
by Volonte, Porta, and Comi (2002).  This study reports features of dysphagia in PD to 
include impaired mouth opening, palatal elevation, and lingual protrusion, and the presence 
of wet voice and/or cough after liquid intake, and infrequently after solids. More robust 
studies have employed instrumental assessments such as VEES (Suntrup et al., 2013), VFSS 
(Ali et al., 1996; Baijens et al., 2011; Hunter, Crameri, Austin, Woodward, & Hughes, 1997; 
Lin et al., 2012; Nagaya et al., 2000; Nagaya, Kachi, Yamada, & Igata, 1998; Stroudley & 
Walsh, 1991), electromagnetic mid-sagittal articulography (EMA) (Van Lieshout, Steele, & 
Lang, 2011), surface electromyography (sEMG) (Nagaya et al., 2000), and pharyngeal 
manometry (Ali et al., 1996) to assess the features of dysphagia in PD. A range of oral and 
pharyngeal dysphagic features has been associated with PD when subjective visual perceptual 
measures are used during instrumental assessment. These features are summarised in Table 
2-1. 
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Table 2-1 - Oral and pharyngeal dysphagia features associated with PD through subjective instrumental 
assessment. 
Feature  Assessment Study 
Anterior spillage VFSS (Stroudley & Walsh, 1991) 
Oral residue VFSS (Ali et al., 1996; Nagaya et al., 2000) 
Lingual tremor VFSS (Ali et al., 1996) 
Tongue pumping VFSS 
sEMG 
(Ali et al., 1996; Nagaya et al., 2000) 
 
Bradykinesia of the 
base of tongue 
VEES (Suntrup et al., 2013) 
Abnormal tongue 
movements and 
reduced bolus control 
VFSS (Stroudley & Walsh, 1991) 
Pre-swallow 
pooling/delayed 
pharyngeal swallow 
VFSS 
VEES 
(Ali et al., 1996; Hunter et al., 1997; Nagaya et al., 
2000; Stroudley & Walsh, 1991; Suntrup et al., 
2013) 
Piecemeal deglutition VFSS (Ali et al., 1996; Nagaya et al., 2000) 
Reduced posterior 
motion of the tongue 
base 
VEES (Suntrup et al., 2013) 
Reduced laryngeal 
elevation 
VEES (Suntrup et al., 2013) 
Vallecular residual VFSS 
VEES 
(Ali et al., 1996; Hunter et al., 1997; Nagaya et al., 
2000; Suntrup et al., 2013) 
Pyriform sinus 
residual 
VFSS 
VEES 
(Ali et al., 1996; Nagaya et al., 2000; Suntrup et al., 
2013) 
Coating of the 
posterior pharyngeal 
wall 
VFSS 
VEES 
(Ali et al., 1996; Suntrup et al., 2013) 
 
Abnormal pharyngeal 
wall movement 
VFSS (Ali et al., 1996) 
Abnormal pharyngeal 
motility 
VFSS (Stroudley & Walsh, 1991) 
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Penetration VFSS 
VEES 
(Hunter et al., 1997; Stroudley & Walsh, 1991; 
Suntrup et al., 2013) 
Aspiration VFSS (Ali et al., 1996; Hunter et al., 1997; Nagaya et al., 
2000; Nagaya et al., 1998; Stroudley & Walsh, 
1991; Suntrup et al., 2013) 
 
Features of dysphagia due to PD identified by more objective, quantifiable measurements are 
summarised in Table 2-2. 
 
Table 2-2 - Oral and pharyngeal dysphagia features associated with PD through objective instrumental 
assessment 
Feature Assessment Study 
Prolonged premotor time  sEMG (Nagaya et al., 2000) 
Smaller tongue movements laterally EMA (Van Lieshout et al., 2011) 
Longer oral transit times VFSS (Nagaya et al., 1998) 
Slowed velopharyngeal closure VFSS (Baijens et al., 2011) 
Longer pharyngeal transit times  VFSS (Lin et al., 2012)  
Delayed pharyngeal swallow VFSS (Lin et al., 2012)  
Increased pressure in the hypopharynx 
 
Pharyngeal 
manometry 
(Ali et al., 1996) 
Reduced variability of hypopharyngeal 
pressure in response to bolus size 
Pharyngeal 
manometry 
(Ali et al., 1996) 
Incomplete UES opening Pharyngeal 
manometry 
(Ali et al., 1996) 
Longer time taken for the UES to open in 
PD individuals who also aspirated 
VFSS (Nagaya et al., 1998) 
 
A number of the swallowing features attributed to those with PD described in Table 2-1 and 
Table 2-2 were also evident in some of the control participants (Ali et al., 1996; Baijens et al., 
2011) but a greater number of PD patients with perceived dysphagia displayed these features 
than PD patients without perceived dysphagia or the control participants. Instrumental 
assessments such as sEMG, EMA, and manometry are quantifiable as data regarding timing, 
muscle activation or pressure is provided. VFSS is open to subjective interpretation but 
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objective measurements and timing of bolus flow and anatomical movement can be applied. 
Reliability data was reported for both subjective and objective measures in two of the studies 
summarised in Table 2-1 and Table 2-2 (Baijens et al., 2011; Nagaya et al., 1998). VFSS is 
the only assessment for which reliability data is reported. The subjectively determined 
features of dysphagia are rated as either present or absent on VFSS without a judgement of 
degree or severity of this feature. Baijens et al. (2011) provide data that reflects stronger 
inter-rater reliability for objective rather than subjective VFSS assessment measures but intra-
rater test-retest reliability is not improved by objective measures. Nagaya et al. (1998) 
reported high intra-rater reliability (ICC > 0.7) across all objective measures but inter-rater 
reliability, although good for both subjective and objective measures, is stronger for the 
subjective measures. This suggests that the measures chosen to assess some aspects of timing 
may involve anatomical features that are difficult to view, or standardized training in the 
definitions of each timing measure may be required. As there is no mention of blinding, it is 
also possible that bias played a role. Although Hunter et al. (1997) do not report reliability 
data, the quantitative measures used were more sensitive to changes in swallowing function 
than subjective measures. 
 
Lin et al. (2012) retrospectively reviewed medical records and compared VFSSs of those 
participants who had a history of aspiration pneumonia to those who did not. Timing 
measures were used to track bolus flow through the oral and pharyngeal cavities. Longer 
swallowing times were found in those with aspiration pneumonia noted in their medical 
histories and this was more pronounced with thicker consistencies.  
 
2.5.5 Swallowing efficiency in Parkinson’s disease 
Lin et al. (2012) also found reduced swallowing efficiency, in terms of speed in which a 
bolus moves through the oral and pharyngeal cavity, to be an important factor relating to 
development of aspiration pneumonia in patients with PD. This finding highlights the 
importance of clinical assessment of swallowing efficiency. 
 
Miller et al. (2009) investigated efficiency of swallowing fluids in 137 individuals with PD. 
Participants were in an ‘off’ medication state and the 150 ml TWST was used. Swallowing 
rate was slower in over 80% of participants compared to the published norms provided by 
Hughes and Wiles (1996). 
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Kanna and Bhanu (2014) investigated performance of 100 patients with PD and 100 age- and 
gender-matched controls on a 150 ml timed water swallowing task. This task differed from 
that used by Hughes and Wiles (1996) because patients were instructed to swallow the water 
at their normal speed and timing commenced with the participant holding the water in their 
mouths. Swallowing speed (ml/s), swallowing volume (ml/swallow), and swallowing 
duration (s/swallow) were then calculated. A PD patient who coughed during this task was 
excluded from analysis indicating that patients with swallowing impairment were under 
represented. Kanna and Bhanu (2014) reported slower swallowing speed, smaller swallowing 
volume, and longer swallowing duration in the PD patients compared to controls. All of the 
differences in swallowing measures between these groups were reported to be statistically 
significant (p < 0.05). However, specific values are not reported and the statistical methods 
used in this study are unclear.  
 
The TOMASS and TWST were used as baseline measures in a pilot study investigating a 
skill-based swallowing rehabilitation approach in PD by Athukorala et al. (2014) which has 
shown promising results for improving swallowing efficiency with a positive impact on 
quality of life. This within-subject design employed solid and fluid swallowing efficiency as 
outcome measures. Surface EMG with electrodes placed on the masseter muscle was used 
during the TOMASS to confirm reliability of visual assessment of masticatory cycles with a 
high level of agreement found between these two measures (ICC > 0.8). Treatment was found 
to result in improvements in the areas of time per swallow and volume per swallow with the 
TWST. Despite improvements in the TWST outcome measure and an observed trend on 
TOMASS measures, there was no improvement seen in the TOMASS performance.  It is 
unclear if this is due to a lack of statistical power in this pilot study, reduced treatment effect 
on the oral phase of swallowing, the mild nature of PD severity among participants, or the 
sensitivity of the TOMASS for detecting change in oral phase swallowing in the PD 
population.  
 
2.6 Aims and Hypotheses 
2.6.1 Aims 
1. To determine whether the TOMASS is a sensitive assessment tool for detecting a 
reduction in swallowing efficiency that may result from the presence of PD. 
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2. To determine whether the TOMASS is a sensitive assessment tool for detecting a 
reduction in swallowing efficiency that may result from increased severity of PD 
motor symptoms. 
3. To determine whether there is a positive relationship between the TOMASS and the 
TWST as objective measures of swallowing efficiency in the PD population. 
 
2.6.2 Research question 1 
Is the TOMASS is a sensitive assessment tool for detecting reduced swallowing efficiency 
that may result from the presence of PD? 
2.6.2.1 Hypothesis 1  
Participants with PD will display reduced performance on the TOMASS compared to healthy 
age and gender matched controls as evidenced by: 
1a) Increased time per-swallow with increased PD severity. 
1b) Increased masticatory cycles per-swallow with increased PD severity.  
1c) Increased swallows per-bite with increased PD severity. 
2.6.2.2 Rationale 
The TOMASS provides a quantifiable measure of efficiency of swallowing a solid bolus. 
Reduced swallowing efficiency has been found to be a result of dysphagia in PD (Lin et al., 
2012; Miller et al., 2009; Umemoto et al., 2011). The TOMASS is likely to be more sensitive 
to impairment of oral phase swallowing than fluid swallowing tests and is able to assess 
mastication. A number of oral phase swallowing impairments have been associated with 
dysphagia in the PD population (Ali et al., 1996; Nagaya et al., 2000; Nagaya et al., 1998; 
Suntrup et al., 2013; Van Lieshout et al., 2011).  
2.6.2.3 Significance  
Prior to the TOMASS being widely adopted for clinical assessment, it needs to be established 
whether or not the TOMASS is sensitive to changes in swallowing resulting from 
neurological impairment.  
 
2.6.3 Research question 2 
Is the TOMASS is a sensitive assessment tool for detecting reduced swallowing efficiency 
that may result from increased severity of PD motor symptoms?  
2.6.3.1 Hypothesis 2  
Performance on the TOMASS will decline with increased PD severity as evidenced by:   
1a) Increased time per-swallow with increased PD severity. 
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1b) Increased masticatory cycles per-swallow with increased PD severity.  
1c) Increased swallows per-bite with increased PD severity. 
2.6.3.2 Rationale 
Dysphagia prevalence rates increase as disease severity increases (Kalf et al., 2012). Reduced 
oral phase swallowing efficiency has been found to correlate with PD severity (Umemoto et 
al., 2011).  
2.6.3.3 Significance 
Self-report regarding the presence of dysphagia has been found to be unreliable in the PD 
population (Ali et al., 1996; Kalf et al., 2012; Miller et al., 2009; Nagaya et al., 2000) and, 
therefore, reliable clinical screening of dysphagia in the PD population is required. Currently, 
severity of PD is assessed by self-report and clinical assessment. By assessing if the 
TOMASS is sensitive to changes in PD severity rather than just the presence or absence of 
PD, a better insight into the sensitivity of the TOMASS and it’s relationship with dysphagia 
will be gained. Reduced swallowing efficiency has been found to be a result of dysphagia in 
PD (Lin et al., 2012; Miller et al., 2009; Umemoto et al., 2011). If the performance on the 
TOMASS is found to correlate with severity of PD this test may assist clinically in the 
prompt identification of dysphagia in PD and provide an additional clinical assessment to 
assist in determination of Parkinson’s severity. Additionally, this test may be a useful 
research tool in studying dysphagia in PD and changes in symptoms.  
 
2.6.4 Research question 3  
Will participant’s performance on the TOMASS correlate with performance on the TWST 
with performance on both tests decreasing as PD severity increases? 
2.6.4.1 Hypothesis 3  
Performance on the TOMASS will have a positive correlation with performance on the 
TWST. 
2.6.4.2 Rationale  
Dysphagia prevalence rates increase as disease severity increases (Kalf et al., 2012). Reduced 
oral phase swallowing efficiency has been found to correlate with PD severity (Umemoto et 
al., 2011). Comparison of performance on the TOMASS with a test that has already been 
validated in this population, The Timed Water Swallowing Test (TWST) may provide further 
insight in to the validity of the TOMASS 
2.6.4.3 Significance  
A greater understanding the differences and relationship between swallowing fluids and 
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swallowing solids in PD may contribute to a greater understanding of the nature of dysphagia 
in PD. There is some indication that swallowing efficiency for solids may be more impaired 
than for liquids in the PD population (Lin et al., 2012) however this has not been thoroughly 
investigated. Because significant improvements after a skill-based treatment were found in 
the TWST but not the TOMASS by Athukorala et al. (2014) the TWST may be more 
sensitive at measuring change in swallowing function than the TOMASS. 
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Chapter 3. Method 
3.1 Participants 
Participants were recruited through specialist PD services and were categorised into four 
groups of participants: 
1) Twenty patients with mild-moderate PD. 
2) Twenty patients with advanced PD. 
3) Twenty healthy controls, age (±5 years) and gender matched to individuals in the 
mild-moderate PD group. 
4) Twenty healthy controls, age (±5 years) and gender matched to individuals in the 
advanced PD group. 
 
Participants with PD were required to have a firm diagnosis of PD as determined by a 
neurologist using the United Kingdom Brain Bank Criteria. Participants were excluded from 
the study if they presented with or had a history of any of the following: 
• Medically diagnosed stroke or traumatic brain injury 
• Neurological illness or muscular disease other than PD 
• Head and/or neck injury/surgery with a potential impact on swallowing (including 
deep brain stimulation) 
• Dementia to a degree where they would be unable to follow instructions or complete 
tasks required for the study 
• Parkinsonism due to progressive supranuclear palsy, multiple system atrophy, or side 
effects of medications 
• Deemed clinically unsafe to participate by the researcher based on information gained 
from the Eating Assessment Tool (EAT-10) questionnaire, medical records or clinical 
assessment. 
 
A record of the number of participants deemed unsafe to participate due to choking or 
aspiration risk was kept. Participants were instructed to continue their medications as per 
usual and assessment was performed at a time of day that PD participants reported they were 
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‘on’ in terms of benefitting from the effects of their PD medications. 
 
Additional data recorded for each participant included age, sex, medications and dose, time 
between last PD medication dose taken and commencement of assessment, and number of 
years post initial PD diagnosis. This information was acquired through a combination of 
participant self-report and medical history review. Signed consent to participate was acquired 
from all participants prior to their participation.  
 
3.1.1 Assignment of Parkinson’s disease severity rating 
Participants with PD were assigned to one of the PD groups based on PD severity determined 
through administration of the MDS-UPDRS part III motor examination (Goetz et al., 2010) 
and assignment of a Hoehn and Yahr severity rating (Goetz et al., 2004). Participants with a 
Hoehn and Yahr rating of I to III were assigned to the mild-moderate PD group. Participants 
with a Hoehn and Yahr rating of IV or V were assigned to the advanced PD group. If a 
control participant matched a participant in age (±5 years) and gender for both PD groups 
they were assigned to both control groups. 
 
3.1.2 Dysphagia survey 
The EAT-10 questionnaire was chosen for use in this study as a dysphagia screening tool. 
This ten item, five point Likert scale design is quick and easy to complete with established 
criterion-based validity, and test-retest reliability. Normative data has been gained and a 
score of ‘3’ is considered as abnormal and therefore indicative of dysphagia. Means and 
ranges for specific dysphagia diagnoses have also been provided (Belafsky et al., 2008) with 
PD contributing to the range of dysphagia aetiologies of the 235 individuals included in 
validation sample. 
 
All participants were provided with the EAT-10 to independently complete once explained 
by the primary researcher. Some participants with PD required assistance to complete this 
questionnaire. When assistance was provided, care was taken to ensure that the individuals 
with PD rather than their carers directed responses.  
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3.2 Procedures 
All experimental tasks were completed in one assessment session by the primary researcher. 
Prior to commencement of the assessment and at times throughout assessment, the researcher 
checked with the participants with PD to ensure they were still “on” or perceptually 
experiencing the benefits of their PD medications. 
 
3.2.1 Timed water swallowing test 
The protocol outlined by Hughes and Wiles (1996) was followed for the TWST with the 
procedure completed twice. A beaker was used to measure 150 ml of water, which was then 
transferred into a cup. Participants were instructed to drink this water “as quickly as is 
comfortably possible”. The number of swallows, time taken and total volume swallowed was 
recorded.  
 
Time taken was recorded with a stopwatch application on an iPhone™. Timing started from 
the moment the water first touched the participant’s lower lip and stopped when the larynx 
came to rest after all water had been consumed. Indicators such as exhalation, phonation or 
mouth opening also assisted in assessing swallow completion. Watching the participant’s 
throat either anteriorly or laterally and counting instances of observable thyroid elevation was 
employed to assess number of swallows.  
 
If participants were unable to drink the entire 150 ml of water due to postural limitations, 
swallowing discomfort, or coughing, the volume swallowed was calculated by measuring the 
remaining water left in the beaker and subtracting this from 150 ml. In the interest of timing 
accuracy, participants were asked to indicate they had finished by placing the cup down if 
they could not drink the entire 150 ml. If anterior spillage of the water was observed during 
completion of the test, a subjective judgement of the amount of water lost was made and 
subtracted from the 150 ml with the presence of anterior spillage noted. Both trials of this test 
were video-recorded using an iPad™ positioned to record in either an anterior or lateral view 
depending on which appeared to best provide an unobstructed view of the lips, jaw, and 
throat.  
 
3.2.2 Test of Masticating and Swallowing Solids 
Each participant completed two trials of the TOMASS. A sip of water was offered to 
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participants prior to each trial. Participants were presented with one quarter of an Arnotts 
Salada™ cracker and instructed, “when I say ‘go’, eat this as quickly as is comfortably 
possible and when you have finished say your name”. Time taken, number of swallows, 
number of masticatory cycles and number of bites were recorded for each trial. 
 
 
 
 
   
   
 
 
 
 
Time taken was recorded using a stopwatch application on an iPhone™. Timing commenced 
as soon as the cracker touched the bottom lip or the teeth and was ceased when the participant 
said their name or produced an utterance or gesture to indicate that they had finished.  
 
The number of swallows was assessed and tallied by watching the participant anteriorly or 
laterally and counting instances of observable thyroid elevation associated with swallowing. 
Auditory cues were also used to assess that swallowing had occurred where possible.  
 
 Number of masticatory cycles was assessed by counting the up then down movement of the 
jaw as one masticatory cycle. Each discrete bite of a segment of the whole cracker was also 
considered to be a masticatory cycle. As masticatory cycles occurred in rapid succession, the 
‘lap’ function of a stopwatch was used to assist in tallying these events. 
 
The number of bites was recorded by counting and tallying the number of discrete cracker 
segments placed in the mouth. For example, if the whole cracker was placed in the mouth at 
once this was counted as one bite. Both trials of this test were video-recorded using an iPad™ 
positioned to record in either an anterior or lateral view depending on which appeared to best 
provide an unobstructed view of the lips, jaw and throat.  
 
The order in which the two swallowing tasks, TOMASS and TWST, were performed was 
Figure 1 - Full size and one-quarter segment of an Arnotts Salada™ cracker 
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alternated from participant to participant to eliminate any bias that performance of one test 
might have on the other. This meant that half the participants in each group did the TOMASS 
before the TWST and half did the TWST before the TOMASS. 
 
3.3 Analysis Plan 
IBM Statistical Package for the Social Sciences Statistics Data Editor software was used for 
data analysis. TOMASS variables analysed included the raw data of total number of bites, 
masticatory cycles and swallows, and total time. From this data, further derived measures of 
masticatory cycles per bite, masticatory cycles per swallow, swallows per bite, time per bite, 
time per masticatory cycle, and time per swallow were calculated for analysis. TWST 
variables analysed were the raw data of number of swallows, total time and volume 
swallowed, derived measures of time per swallow, volume per swallow and volume per time. 
For all analyses of TOMASS and TWST measures, data from the second trial were used, as 
the first trial was considered a practice trial, with the exception of test-retest reliability where 
both trials were compared. 
 
3.3.1 Reliability analyses 
Reliability analyses were conducted on all TOMASS and TWST raw data variable with the 
exception of volume because this measurement was only performed by the primary 
researcher.  Type A intraclass correlation coefficients using an absolute agreement definition 
and a two-way random effects model were used for reliability analyses.  Intraclass correlation 
coefficient can be interpreted as follows: 0.0-0.2 poor agreement, 0.3-0.4 fair agreement, 0.5-
0.6 moderate agreement, 0.7-0.8 strong agreement, and >0.8 almost perfect agreement 
(Portney & Watkins, 2000). 
 
The 66 participants were randomized. The first 14 (approximately 20%) participants with 
video recordings displaying unobstructed second TOMASS and TWST trial images were 
reviewed. This selection resulted in inter- and intra-rater reliability analyses being conducted 
on five control participants, four mild-moderate PD participants, and five advanced PD 
participants.  
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3.3.1.1 Test-retest reliability 
Test-retest reliability analyses were conducted on 65 of the 66 participants for the TOMASS. 
One participant’s first TOMASS trial was omitted because of an interruption during the trial. 
Data from all 66 participants for the TWST were analysed.  
 
3.3.1.2 Intra-rater reliability 
The primary researcher rated video recordings twice with two days between each rating 
session. Intra-rater reliability analyses were performed on the ‘real-time’ rating and both 
video review ratings with three separate ratings per test variable analysed in total. 
 
3.3.1.3 Inter-rater reliability 
Two final year speech language therapy (SLT) students received a one hour training and 
practice session in rating the TWST and the TOMASS. Video recordings were reviewed and 
rated by the two SLT students separately. Inter-rater reliability analyses were conducted 
using the two SLT student ratings and the ‘real-time’ rating of the primary researcher (3 
raters in total). 
 
The inter-raters were blinded to the group assignment of the 14 participants rated and were 
asked to indicate whether or not they considered each participant had PD. A percentage of 
correct responses were then calculated to determine the level of blinding achieved.  
 
3.3.2 Between-group analyses 
Initial distribution analyses of TOMASS, TWST, and age data were completed. As the 
majority of the data were found to differ from a normal distribution based on findings from 
the Kolmogorov-Smirnov test and Levene’s test, non-parametric tests were subsequently 
used for analyses. A Mann-Whitney test was the non-parametric test considered to be the 
most appropriate test for comparison of the level of difference in performance of each 
variable between groups and whether or not this difference was significant. Pearson’s 
correlation coefficient r effect size was then calculated using the method outlined by Field 
(2011). In interpreting this effect size, 0.5 is the threshold for a large effect size, 0.3 for a 
medium effect, and 0.1 a small effect. However, for an effect to be clinically relevant in this 
population, an effect size larger than 0.5 would be indicated. Analyses between the PD 
groups of  20 and their matched groups of 20 controls, both PD groups, and a group formed 
of all 40 patients with PD and a group formed of all 26 control participants were performed. 
  
30 
 
A one-tailed Spearman’s correlation coefficient was the non-parametric test used to further 
investigate the relationship between TOMASS and TWST performance and MDS-UPDRS 
PD severity score. The 40 PD participants were included in these analyses. 
 
3.3.3 Between-test analyses 
Spearman’s correlation coefficient was the non-parametric test used to investigate the 
relationship between performance on the TWST and performance on the TOMASS. The 
relationship between TOMASS raw data measures and the total EAT-10 score was also 
analysed using Spearman’s correlation coefficient. Initially all 66 participants were included 
in theses analyses. The control participants were removed from these analyses to eliminate 
bias and analyses were completed on the 40 participants with PD. Because positive 
relationships were hypothesised, one-tailed analyses were selected.  
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Chapter 4. Results 
4.1 Reliability  
Table 4-1 displays the intraclass correlation coefficients (ICC) for each of the TOMASS and 
TWST measures. Almost perfect agreement was seen across all measures of the TOMASS 
and TWST for test-retest and intra-rater reliability, indicating that participants were 
consistent in their performance of both tests from one trial to the next, that real-time intra-
rater reliability between trial one and trial two was high, and video-recordings of these tests 
provided adequate clarity in order to complete ratings. Almost perfect inter-rater agreement 
was seen across both measures of the TWST and all TOMASS measures with the exception 
of swallows, which achieved moderate inter-rater agreement. There was no clear discrepancy 
between the rating of one rater compared to the other two raters in any of the measures, 
however, the real-time ratings had a general trend toward higher number of swallows.  Only 
minor improvements were seen in the intraclass correlation coefficients for TOMASS 
swallows (0.76) when video ratings of all three raters were compared. This was not a trend 
observed across all measures.  
 
Table 4-1 – Reliability data for TOMASS and TWST measures  
 
 
 
 
Test 
Measure 
Test-retest reliability Intra-rater reliability Inter-rater reliability 
 
 
ICC 
Average 
Measures 
95% 
Confidence 
Interval 
 
 
ICC 
Average 
Measures 
95% 
Confidence 
Interval 
 
 
ICC 
Average 
Measures 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Lower 
Bound 
Upper 
Bound 
Lower 
Bound 
Upper 
Bound 
TOMASS          
Bites .82* .71 .89 .98* .95 .99 .97* .93 .99 
Masticatory 
cycles 
.95* .91 .97 .99* .96 .99 .99* .96 .99 
Swallows .89* .81 .93 .84* .61 .95 .67 .21 .88 
Time .97* .96 .98 1.00* 1.00 1.00 1.00* .99 1.00 
TWST          
Swallows .93* .89 .96 .97* .92 .99 .93* .83 .98 
Time .99* .98 .99 .99* .99 1.00 .99* .99 .99 
Type A intraclass correlation coefficients using an absolute agreement definition. Two-way random effects 
model >0.8* = almost perfect agreement. 
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It was noted that number of swallows was more difficult to assess in women than men and 
most difficult to assess in PD participants with dyskinesia. This subjective observation was 
reinforced by the finding that the greatest variance between raters was seen in a female PD 
participant with marked dyskinesia’s causing additional movements of the neck and throat. 
The variance in number of TOMASS swallows assigned by each rater for the same 
participant ranged from 0 to 6 swallows with a median of 1 and a mean of 1.6. The impact of 
this participant on inter- and intra-rater reliability of TOMASS and TWST swallows was 
explored by assessing reliability if this participant’s data was excluded. There was no change 
to TWST reliability, minimal improvement to TOMASS intra-rater reliability (.89). Inter-
rater reliability, however, increased from moderate (.67) to strong (.80). 
 
The presence or absence of PD was correctly determined in 78% and 82% of participants 
respectively by each blinded inter-rater. These figures indicate that blinding was limited.  
 
4.2 Participants and group composition 
A total of 74 participants consented to participate in this study. Data collection was 
completed on 68 of these participants with two of these participants later excluded from the 
study. A mild-moderate PD participant reported that he did not believe his PD medications 
were effective. Although his rationale related to ongoing symptoms caused by a coexisting 
disorder unrelated to PD, this participant’s data were later excluded because they did not 
meet the inclusion criteria of a perceived feeling of benefitting from PD medications at the 
time of the assessment. A control participant was excluded due to ongoing dysphagic 
symptoms secondary to minor head and neck surgery that was reported after data collection.  
 
Of the 44 patient participants who completed the MDS-UPDRS motor examination for 
potential inclusion, four PD participants were informed that they did not meet the PD severity 
criteria for the study. Two advanced PD participants were not able to complete or declined 
completion of the swallowing tasks with one declining to wear dentures and unable to bite the 
cracker to complete the experimental procedures and the other reporting that they avoid 
drinking due to continence issues and declined to drink an adequate amount to be included in 
data analysis.  
  
33 
 
One individual with advanced PD had a history of surgery for decompression of the facial 
nerve due to eyelid twitching; however, this surgery did not result in any impairment to the 
facial nerve, nor other swallowing related structures and therefore this participant was not 
excluded from the study. Twelve participants had documented dementia in their medical 
history (11 in the advanced PD group and one in the mild-moderate PD group). 
 
Three individuals, whom, based on their observed mobility, would likely have met the 
advanced PD group criteria, were deemed unsafe to participate or declined to participate due 
to the severity of dysphagia. Two of these participants had undergone a recent VFSS and 
were prescribed puree diets as a result. The third individual declined participation due to a 
fear of choking. 
 
In total, analyses were performed on the data collected from 66 individuals: 20 with mild-
moderate PD; 20 with advanced PD and 26 healthy controls. Data from 14 of the 26 control 
participants were used across both control groups. 
 
Both the mild-moderate and advanced PD groups were matched 1:1 for gender with their 
control groups. The overall PD group had a slightly higher (2%) representation of males than 
the overall control group.  
 
There was no significant difference in participant age between the control for mild-moderate 
PD group (Mdn = 69.50) and the mild-moderate PD group (Mdn = 69.00), U = 195.5, z = -
.122, p = .45, r = - .019. This was also true for the advanced PD group (Mdn = 74.50) and 
their control group (Mdn = 72.50), U = 193.0, z = -.190, p = .43, r = - .030 indicating that the 
control groups were successfully age matched to their respective PD groups. There was no 
significant difference in participant age when all control participants were grouped (Mdn = 
70.00) and all PD participants grouped (Mdn = 72.00), U = 518, z = -.026, p = .49, r = - .003. 
Participant age between the mild-moderate PD group (Mdn = 69.00) and the advanced PD 
group (Mdn = 74.50) did, however, differ with the advanced PD group older than the mild-
moderate PD group, U = 119.5, z = -2.181, p = .014, r = - .345.  
 
Detailed figures and descriptive statistics for participants and group distribution are presented 
in the Appendix. 
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4.3 TOMASS and TWST between-group analysis 
4.3.1 Parkinson’s disease group vs control group 
As displayed in Table 4-2, there were differences in TOMASS measures of total time, total 
number of swallows, and total number of masticatory cycles between participants with PD 
and healthy age matched controls. All TWST raw and derived measures reached significance 
between these groups. None of the TOMASS derived measures displayed between-group 
differences. 
 
Table 4-2 - Comparison of TOMASS and TWST performance between all control participants and all PD 
participants. 
Test Measure Median 
control  
n=26 
Median 
PD  
n=40 
Mann-
Whitney 
U 
p-value  
(1-tailed) 
z-score r - effect 
size 
TOMASS       
Bites 2.5 3.0 399 .053 -1.621 -.123 
Masticatory cycles 55.0 69.5 301 .002* -2.875 -.354 
Swallows 2.0 3.0 377 .027* -1.920 -.236 
Time (s) 43.5 61.8 307 .002* -2.795 -.344 
Masticatory cycles / bite 21.5 25.6 445 .166 -.978 -.120 
Masticatory cycles / swallow 24.0 29.1 491 .354 -.381 -.047 
Swallows / bite 1.0 1.0 492 .356 -.375 -.046 
Time / bite (s) 9.4 7.0 437 .141 -1.083 -.133 
Time / masticatory cycle (s) .84 .83 518 .491 -.026 -.003 
Time / swallow (s) 20.6 24.4 445 .165 -.984 -.121 
TWST       
Swallows 6.0 10.0 244 .000* -3.911 -.481 
Time (s) 11.2 25.9 399 .000* -3.622 -.446 
Volume (ml) 150 150 223 .042* -2.053 -.253 
Time / swallow (s) 1.5 2.1 346 .011* -2.283 -.281 
Volume / swallow (ml) 25.0 15.0 221 .000* -3.935 -.484 
Volume / time (ml/s) 13.5 5.8 240 .000* -3.674 -.452 
*p < .05 
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4.3.2 Mild-Moderate PD group vs Mild-Moderate PD control group 
As displayed in Table 4-3, there were only differences in TOMASS total time between the 
mild-moderate PD group and their age-matched control group. By contrast, there were 
differences in all TWST measures between these groups with the exception of volume. 
 
Table 4-3 - Comparison of TOMASS and TWST performance between the control group for mild-
moderate PD and the mild-moderate PD group. 
Test Measure Median 
control  
n = 20 
Median mild-
moderate PD 
n = 20 
Mann-
Whitney 
U 
p-value  
(1-tailed)  
z-score r effect 
size 
TOMASS       
Bites 2.5 3.0 175 .251 -.698 -.110 
Masticatory cycles 56.5 68.5 143 .063 -1.543 .244 
Swallows 2.0 2.0 177 .268 -.630 -.099 
Time (s) 43.5 57.8 134 .038* -1.785 -.282 
Masticatory cycles / bite 22.0 22.3 195 .449 -.135 -.021 
Masticatory cycles / swallow 25.8 30.3 197 .476 -.068 -.011 
Swallows / bite 1.0 1.0 196 .464 -.097 -.153 
Time / bite (s) 8.8 6.8 180 .301 -.541 -.086 
Time / masticatory cycle (s) .79 .81 184 .337 -.433 -.068 
Time / swallow (s) 20.8 27.2 173 .239 -.730 -.115 
TWST       
Swallows 6.0 8.5 101 .003* -2.686 -.425 
Time (s) 10.0 16.1 109 .007* -2.462 -.389 
Volume (ml) 150 150 180 .244 -1.432 -.226 
Time / swallow (s) 1.50 1.75 138 .048* -1.677 -.265 
Volume / swallow (ml) 25.0 17.7 100 .003* -2.713 -.429 
Volume / time (ml/s) 15.2 9.0 109 .007* -2.462 -.389 
*p<.05) 
 
4.3.3 Advanced PD group vs Advanced PD control group 
As displayed in Table 4-4, there were differences in all TOMASS raw data measures between 
participants with advanced PD and the healthy age-matched controls but none of the 
TOMASS derived measures. There were differences in all TWST measures between these 
groups with the exception of volume. 
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Table 4-4 - Comparison of TOMASS and TWST performance between the control group for Advanced 
PD and the Advanced PD group 
Test Measure Median 
control 
 n = 20 
Median 
advanced 
PD 
n = 20 
Mann-
Whitney 
U 
 p-value 
(1-tailed) 
z - score r effect 
size 
TOMASS       
Bites 2.0 3.5 125 .019* -2.085 -.329 
Masticatory cycles 54.0 88.0 94 .002* -2.868 -.453 
Swallows 2.0 3.0 102 .003* -2.730 -.432 
Time (s) 42.3 71.4 102 .004* -2.651 -.419 
Masticatory cycles / bite 22.0 29.3 164 .169 -.974 -.154 
Masticatory cycles / swallow 25.8 29.1 195 .455 -.122 -.019 
Swallows / bite 1.0 1.0 176 .262 -.652 -.103 
Time / bite (s) 9.7 7.0 147 .080 -1.420 -.225 
Time / masticatory cycle (s) .83 .84 196 .460 -.108 -.017 
Time / swallow (s) 20.6 23.3 184 .339 -.433 -.068 
TWST       
Swallows 6.5 11.0 59 .000* -3.818 -.604 
Time (s) 11.2 26.5 64 .000* -3.679 -.582 
Volume (ml) 150 150 160 .053 -2.079 -.329 
Time / swallow (s) 1.5 2.5 114 .010* -2.326 -.368 
Volume / swallow (ml) 23.2 13.6 59 .000* -3.831 -.606 
Volume / time (ml/s) 13.4 5.5 61 .000* -3.760 -.594 
*p<.05 
 
4.3.4 Mild-Moderate PD group vs Advanced PD group 
As displayed in Table 4-5, there were no differences between the PD groups on any 
TOMASS or TWST measures. However, when comparing TOMASS and TWST measures 
across assigned MDS-UPDRS part III – motor examination ratings, positive correlations 
between increasing PD severity and increasing values on TOMASS masticatory cycles and 
time per masticatory cycle and TWST time, swallows, volume per swallow, and volume per 
time were found (Table 4-6). 
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Table 4-5 - Comparison of TOMASS and TWST performance between the mild-moderate PD group and 
the advanced PD group 
Test Measure Median 
mild-
moderate 
PD 
n = 20 
Median 
advanced 
PD 
n = 20 
Mann-
Whitney 
U 
p-value 
(1-tailed) 
z-score r effect 
size 
TOMASS       
Bites 3.0 3.5 158 .131 -1.142 -.181 
Masticatory cycles 68.5 88.0 142 .061 -1.556 -.246 
Swallows 2.0 3.0 156 .118 -1.197 -.189 
Time (s) 57.8 71.4 158 .132 -1.136 -.179 
Masticatory cycles / bite 22.3 29.3 176 .262 -.649 -.103 
Masticatory cycles / swallow 30.3 29.1 190 .397 -.271 -.043 
Swallows / bite 1.0 1.0 176 .265 -.642 -.102 
Time / bite (s) 6.8 7.0 189 .392 -.284 -.045 
Time / masticatory cycle (s) .81 .84 195 .449 -.135 -.021 
Time / swallow (s) 27.2 23.3 184 .339 -.433 -.068 
TWST       
Swallows 8.5 11.0 139 .051 -1.643 -.260 
Time (s) 16.1 26.5 147 .079 -1.434 -.227 
Volume (ml) 150 150 179 .187 -.915 -.145 
Time / swallow (s) 1.8 2.5 173 .239 -.730 -.115 
Volume / swallow (ml) 17.7 13.6 142 .061 -1.559 -.246 
Volume / time (ml/s) 9.0 5.5 148 .083 -1.407 -.222 
*p<.05 
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Table 4-6 - Relationship between TOMASS and TWST performance and MDS-UPDRS part III – motor 
examination PD severity ratings for the 40 PD participants  
Test Measure Spearman’s Correlation Coefficient rs 
(1-tailed) 
TOMASS  
Bites .16 
Masticatory cycles .29* 
Swallows .10 
Time (s) .01 
Masticatory cycles / bite .08 
Masticatory cycles / swallow .10 
Swallows / bite -.02 
Time / bite (s) -.13 
Time / masticatory cycle (s) -.33* 
Time / swallow (s) -.13 
TWST  
Swallows .30* 
Time (s) .27* 
Volume (ml) -.14 
Time / swallow (s) .13 
Volume / swallow (ml) -.28* 
Volume / time (ml/s) -.27* 
*p<.05 
 
Detailed figures relating to between group analyses are presented in the Appendix. 
 
4.4 Between-test analysis 
4.4.1 TWST and TOMASS 
TOMASS time was related to TWST time, rs = .41, p < .01. There was also a relationship 
between TOMASS swallows and TWST swallows, rs = .49, p < .01. However, there was no 
significant relationship between the derived measures of TOMASS time per swallow and 
TWST time per swallow, rs = .04, p  = .41.   
 
4.4.2 EAT-10 and TOMASS 
Total EAT-10 score was related to TOMASS time, rs = .41, p < .01 and swallows, rs = .39, p 
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< .01. There was no significant relationship between total EAT-10 score and masticatory 
cycles, rs = .22, p = .090, and bites rs = .24, p = .069 when only the PD participants were 
included in the analyses.  
 
Detailed figures relating to between test analyses are presented in the Appendix. 
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Chapter 5. Discussion  
This study contributes to a body of evidence being developed on the sensitivity, validity, and 
clinical application of the TOMASS.  
 
5.1.1 Reliability 
The high reliability of TOMASS measures displayed in this study indicates that the 
TOMASS is indeed a quantifiable and objective measure of solid food swallowing. If the 
TOMASS is found to be a valid dysphagia assessment tool, its use would increase the 
reliability of the oral trial component of the CSE. There is some indication that inter-rater 
reliability of the TOMASS number of swallows variable might be reduced in neurogenic 
populations where the presence of dyskinesias may obstruct a clear view of the head and neck 
area during assessment. Battel, Koch, and Huckabee (2015) compared the swallowing 
efficiency of 23 individuals with PD, 23 individuals with multiple sclerosis, and 22 matched 
controls using the same TOMASS and 150 ml TWST procedures as the current study. The 
moderate inter-rater reliability for TOMASS number of swallows found in the current study 
is also reported by Battel et al. (2015) (ICC = .67). All other TOMASS and TWST variables 
displayed ‘almost perfect agreement’ (ICC >.90) (Battel et al., 2015). In contrast, ‘almost 
perfect’ inter-rater agreement on TOMASS number of swallows was observed by Athukorala 
et al. (2014) where all individuals in the patient group were reported to have mild-moderate 
PD. The differences in PD severity between these studies may account for reduced reliability 
for swallows in this study. The discrepancy in reliability of the number of swallows between 
the TOMASS and the TWST seen in this study could be explained by the presence of hyoid 
movement during mastication and the transfer cycle (Palmer et al., 1992). This occurs during 
ingestion of solid but not liquid boluses and could be misinterpreted as a swallow.  
 
5.1.2 Presence of PD and swallowing efficiency  
The increase in TOMASS total time, total number of swallows, and total number of 
masticatory cycles in the PD group compared to the control group indicates that the 
TOMASS, like the TWST, is sensitive enough to detect changes in swallowing function 
resulting from PD. The effect size of these TOMASS findings was, however, small. Battel et 
al. (2015) found that patients with PD had a greater total time, number of swallows and 
masticatory cycles on the TOMASS and also a greater total time and number of swallows on 
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the TWST when compared to healthy controls, reinforcing the findings of the current study. 
The severity of the patients with PD or multiple sclerosis was not reported by Battel et al. 
(2015) but no difference in TOMASS and TWST performance was observed between the PD 
and MS groups. The MS group differed from the group of healthy control participants on the 
TOMASS measures but not the TWST measures. Battel et al. (2015) proposed that reduced 
efficiency of swallowing solids may be a more sensitive measure of the presence of 
dysphagia than efficiency of swallowing fluids.  
 
5.1.3 PD severity and swallowing efficiency 
The more pronounced differences between the advanced PD group and control group, 
compared to the mild-moderate PD group and control group, indicates that the TOMASS is 
sensitive to increasing PD severity and appears to support the premise of Hypothesis 2. 
However, when the mild-moderate PD groups TOMASS performance was compared directly 
with the advanced PD groups TOMASS performance, there were no significant differences in 
all areas of the TOMASS. The number of masticatory cycles was the only TOMASS measure 
to show a positive relationship with PD severity and all correlations were low.  
 
The low correlations and small effect sizes reported in this study for significant TOMASS 
variables indicate that relationships may not be clinically significant. However, it is possible 
that these findings were influenced by population bias. Participants who presented with 
severe dysphagia were excluded from this study due to safety concerns in completing the 
swallowing tasks and participants with no perceived dysphagia were included. Furthermore, 
only two participants presented with the most severe Hoehn and Yahr PD classification 
representing only 10% of the advanced PD group and 5% of the total PD group. A stronger 
relationship between TOMASS performance and PD severity may have been found if the 
participants were more representative of a clinical population. 
 
It should also be noted that there was a wide range in performance of the TOMASS between 
individuals, with some individuals with PD being more efficient at completing these 
assessments than some of the individuals in the control group. This indicates that, like other 
dysphagia assessments, there may be issues regarding specificity of the TOMASS.  However, 
further research into the validity of the TOMASS is required. 
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5.1.4 Relationship between TOMASS and TWST 
There was a positive relationship between the TOMASS and TWST raw data measures of 
time and number of swallows indicating that the TOMASS is a solid food correlate to the 
150 ml TWST presented by Hughes and Wiles (1996). The findings of this study indicate that 
the TOMASS and TWST have similar levels of sensitivity in response to PD severity 
although the TWST has a higher degree of significance and larger effect sizes on more 
measures, indicating that the TWST may be slightly more sensitive than the TOMASS as a 
measure of swallowing efficiency within the PD population. 
 
5.1.5 Raw data vs derived measures 
In the current study, although there were differences in the raw data measures for TOMASS 
between groups, differences were not observed in the derived measures. This was also noted 
by Battel et al. (2015). By contrast, many of the derived measures for the TWST displayed 
differences in both studies. A similar trend of the raw data showing differences reflected in 
more TOMASS raw data than derived measures was also seen in the TOMASS normative 
data study by Huckabee et al. (2015). 
 
The same time per swallow could result from few swallows over a short time, or many 
swallows over a long time. Consequently, a shorter time per swallow is not always reflective 
of increased swallowing efficiency. The same logic applies to the derived measures of time 
per bite and time per masticatory cycle. The difference for the TWST compared to the 
TOMASS being that liquid ingestion requires minimal oral preparatory time with prompt 
swallowing onset on transfer into the pharynx, allowing for a more rapid and reflexive 
swallowing plan than solid ingestion (Palmer et al., 1992). The increased number of variables 
in the TOMASS allows for additional influences of one variable on another. For example, 
difficulty masticating could result in an increased total time and impact on the derived 
measure of time per swallow. The TWST derived measures are, therefore, more likely to 
reflect the raw data measures than the TOMASS derived measures would. 
 
It was hypothesised that changes in TOMASS derived measures between groups would 
provide evidence for the sensitivity of the TOMASS. On reflection, changes in TOMASS raw 
data measures are more reflective of swallowing efficiency and therefore provide evidence 
for the sensitivity of the TOMASS. The treatment study completed by Athukorala et al. 
  
43 
(2014) only used the derived measures as TOMASS outcome measures, which could explain 
why changes were seen post-treatment in the TWST but not the TOMASS in that study. 
 
5.2 Limitations of the study 
5.2.1 Dentition  
The design of this study did not control for impact of dentition on ability to complete the 
TOMASS. Data was not collected on the presence or condition of each participant’s 
dentition. A study by Mishellany-Dutour, Renaud, Peyron, Rimek, and Woda (2008a), 
comparing the efficiency and success of mastication of solid foods between dentate young, 
dentate elderly, and elderly denture wearing adults suggests that dentures and age have a 
impact on efficiency in masticating solid foods. Those with dentures required the most 
masticatory cycles and were the least successful in masticating a bolus prior to a swallow. 
Warren et al. (2002) evaluated dental status and tooth loss in a longitudinal study of healthy 
aging adults and found that number of missing teeth rather than dental condition had in 
impact on quality of life measures including ease of chewing and ability to manage and 
swallow solid foods. The literature, therefore, suggests that dental status would impact on 
TOMASS completion and this would have been a relevant variable to include in the analyses 
and compare across groups. 
 
The literature also suggests that individuals with PD may be at greater risk of having poor 
dentition than healthy age-matched participants. Nakayama, Washio, and Mori (2004) 
surveyed the oral health of 104 individuals and compared findings with a control group. 
Those with PD performed less oral hygiene care activities and had more difficulty chewing 
and more denture discomfort than the controls. The idea that the PD population may have 
poorer dentition which in turn may contribute to difficulty with mastication and therefore 
completion of the TOMASS was reinforced in a study completed by Pradeep et al. (2013). 
They completed comprehensive evaluations of the dentition of 45 individuals with PD and 46 
age- and gender-matched controls. Participants were required to have a minimum of ten teeth 
and were excluded if they had a history of other health factors that may impact on oral health 
such as smoking or diabetes. The dental examiners were blinded to the objectives of the 
study. Findings included the presence of more dental decay with increasing severity of PD. 
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Even the mild PD group (Hoehn and Yahr rating of I) presented with a poorer dental 
condition than their matched controls.  
 
Bakke, Larsen, Lautrup, and Karlsborg (2011) comprehensively evaluated the orofacial 
function and oral health of fifteen PD patients and compared their performance with age- and 
gender-matched controls. Objective assessment of masticatory performance and efficiency, 
oral stereognosis, jaw opening capacity, number of natural teeth and subjective evaluation of 
oral hygiene, dental condition and orofacial function was performed. Those with PD reported 
mastication to be more impaired and the presence of oral health problems more frequently 
than the controls did. The masticatory effectiveness was poorer in the PD group and appeared 
to become poorer with increasing PD severity. Masticatory efficiency, measured by total time 
taken to chew a standardised solid bolus from the first bite to first swallow, did not differ 
between groups. Jaw opening capacity was reduced in the PD group. The PD group also 
displayed poorer oral hygiene than the controls but there were no differences in number of 
natural teeth between groups.  
 
Findings from these studies suggest that individuals with PD are at a higher risk of poor oral 
health, which may lead to fewer teeth and a greater need for dentures. However, dentition 
may have a stronger impact on efficiency of mastication than PD itself. This needs to be 
considered when interpreting the relationship between masticatory cycles and PD severity 
found in this study. 
 
5.2.2 Measurement 
Oral residual was noted to be present on completion of the TOMASS among participants in 
all groups. No attempt to quantify the amount of oral residual was made. Oral residual can 
indicate oral phase dysphagia. As oral residual was present in individuals across all groups it 
was felt that differences in interpretations of the instructions may have occurred. Some 
individuals indicated that they had “finished” after their first swallow had cleared the bulk of 
the bolus. Others made an attempt to clear every morsel of cracker from their mouth before 
indicating they had finished by stating their name. The TOMASS total time, although 
quantifiable, is impacted by participant’s subjective interpretation of the instructions. Any 
attempt to estimate the amount of oral residual for consideration in analyses would introduce 
a level of subjectivity that should be avoided in an otherwise quantifiable assessment. 
Unfortunately, anterior spillage during the TOMASS and TWST occurred with some 
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participants. Because volume swallowed is one of the TWST measures, the volume of spilt 
water had to be subjectively estimated by the examiner rather than objectively measured. 
Therefore, reducing the reliability of volume and derived measures relating to volume in this 
study.   
 
5.2.3 Bias 
An attempt was made to control for any bias concerning the presence of PD and TOMASS 
and TWST measures by blinding the two inter-raters to group assignment. However, it is 
acknowledged that in reviewing video-recordings it may be apparent which participants have 
PD. Although group assignment was not obvious for all participants, blinding was limited, 
and therefore bias was not well controlled for in this study. The high degree of inter-rater 
reliability across measures, however, does give an indication that bias is limited in measures 
which are largely objective. 
 
The advanced and mild-moderate PD groups were not actively matched to each other for age 
and gender with the advanced PD group being older than the mild-moderate PD group. 
Increased age results in an increase in masticatory cycles and reduced masticatory 
effectiveness (Mishellany-Dutour, Renaud, Peyron, Rimek, & Woda, 2008b). Despite this, 
there were no significant differences in any TOMASS or TWST variables, so the age 
difference does not appear to bias outcomes. A regression analysis would better compare the 
relationship between performance on these swallowing tests and PD severity given that the 
groups are not matched. This type of analysis would also increase the power of the study. 
However, the bootstrapping procedure required for this analysis is beyond the scope of a 
Master’s thesis. 
 
The height and weight of participants was not recorded in this study. Height impacts on 
swallowing capacity in the TWST (Hughes & Wiles, 1996) and low body mass index has 
been positively correlated with increased dysphagia severity (Lam et al., 2007). Therefore, it 
would be relevant to include height and weight in the analyses to gain a better understanding 
of possible discrepancies between groups. 
 
This study attempted to account for any effect that medication may have on completion of 
swallowing tests and assessment of PD severity. There is a large variation in the regularity 
and effectiveness of medication doses between patients. Subjective patient report was relied 
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upon to determine whether participants were benefitting from their medications at the time of 
the assessment and levodopa dose was not controlled for between the two PD groups. 
Inaccuracies in this subjective report may have impacted on the MDS-UPDRS assessment as 
medication has a known effect on motor skills (Hunter et al., 1997). Lim, Leow, Huckabee, 
Frampton, and Anderson (2008) found that PD medications did not impact on the TWST 
performance. Battel and Huckabee (2014b) investigated the influence of levodopa on 
performance of the TOMASS and TWST in 38 individuals with PD. There was no significant 
difference between individuals performance on these tests whether they were “on” or “off” 
medication but this study was low in statistical power. Hunter et al. (1997) did find 
differences in swallowing speed of semi-solids and solids “on” and “off” medications. 
Monte, da Silva-Junior, Braga-Neto, Nobre e Souza, and de Bruin (2005), however, found 
that patients with a higher levodopa dose had greater oral-pharyngeal swallowing efficiency. 
 
5.2.4 Dysphagia screening 
This study did not directly evaluate the relationship between performance on the TOMASS 
and the presence of oral or pharyngeal dysphagia. An instrumental assessment of swallowing 
such as VFSS is necessary to confirm the presence or absence of dysphagia and assess the 
validity of the TOMASS in screening for dysphagia. The positive relationship between 
TOMASS measures, TWST measures and EAT-10 score, however, does indicate that there is 
a relationship between reduced efficiency in the TOMASS and the presence of dysphagia.  
 
The EAT-10 was chosen as part of a dysphagia screen for this study. Although patients with 
PD were used as part of the validation process for the EAT-10, it was not validated 
specifically for PD (Belafsky et al., 2008). It may have been more relevant to use the 
Swallowing Disturbance Questionnaire that was validated on 57 outpatients with PD by 
Manor et al. (2007) and found to have 80.5% sensitivity and 81.3% specificity for identifying 
the presence of dysphagia.  
5.3 Future research directions 
From the data collected in this study, further analyses could be completed to gain a greater 
understanding of the TOMASS in relation to PD and dysphagia. These analyses exceed the 
limits of this thesis document. The relationship between TOMASS and TWST measures and 
ratings of each individual EAT-10 question would provide further insights into the 
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relationship between reported difficulties specific to solids or liquids and actual performance 
ingesting these textures. Investigating the relationship between TOMASS measures and 
specific motor ratings on the MDS-UPDRS part III could provide further insight into 
connections between areas of motor impairment resulting from PD and swallowing 
impairment resulting from PD. Additionally, further statistical analyses would provide a 
stronger insight into PD severity as determined by the MDS-UPDRS and TOMASS and 
TWST measures. A linear regression analysis across MDS-UPDRS ratings on each of the 
swallowing test measures would provide more accurate insight into PD severity and 
TOMASS and TWST performance. 
 
The presence of other documented indicators of dysphagia such as coughing, throat clearing, 
wet voice, and anterior spillage during or after oral intake, although noted during and post 
completion of the TOMASS and TWST, were not analysed for the purpose of this study. Wu 
et al. (2004) found that the sensitivity of the TWST increased when these measures were 
considered in clinical assessment. Further analyses of these more subjective dysphagia 
symptoms in combination with objective measures might reveal a stronger relationship 
between PD severity and swallowing impairment indicated through performance of the 
TOMASS. Anterior spillage and oral residual have been reported to be present in PD with 
anterior spillage found to be a strong indicator of dysphagia in PD (Lam et al., 2007). This 
study does not report the sensitivity or specificity of the TOMASS in identifying dysphagia 
in PD and further research in this area might be warranted. 
 
This research compared performance on the TOMASS with other swallowing tests that have 
displayed an ability to indicate the presence of dysphagia such as the TWST and EAT-10 
with positive relationships found. However, the current study did not directly investigate the 
relationship between TOMASS performance and the presence of dysphagia. Further research 
to investigate the validity of the TOMASS in clinically assessing the presence of dysphagia is 
warranted to determine further clinical application of the TOMASS within PD and other 
neurological populations. The use of instrumental swallowing assessment such as VFSS is 
recommended for this research. 
 
Prior to future research on the TOMASS, considerations around administration of the 
TOMASS should be made. These considerations should include increasing the detail within 
the instructions for the TOMASS to reduce subjective interpretation, or changing the 
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guidelines to stop timing once a swallow has occurred to help to increase the objectivity of 
the TOMASS.  
 
It is recommended that future research on the TOMASS: 
• Control for dentition, particularly number of teeth, and the presence of dentures 
because this has been identified as a potential stronger influence on mastication time 
and effectiveness than neurological impairment. 
• Use only TOMASS raw data in analyses, as the derived measures are less reflective of 
swallowing efficiency.  
• Employ blinding to eliminate bias. 
• Continue to use the TWST as a water-swallowing correlate. 
 
5.4 Conclusions 
The TOMASS shows merit as a swallowing screening tool and also as a treatment outcome 
measure provided that the raw data are used in the analyses. This study reinforces the finding 
by Battel et al. (2015) that the TOMASS is a sensitive assessment of reduced solid food 
swallowing efficiency caused by PD. The presence of PD rather than severity appears to have 
a stronger influence on reduced swallowing efficiency, however, PD severity does appear to 
play a role. Although differences in TOMASS variables between groups were found, the 
effect sizes are small, reducing the clinical applicability of these findings. However, the small 
effects seen could be explained by a population bias within this study because the participants 
were not representative of patients presenting clinically for swallowing assessment. The 
number of masticatory cycles appears to be the most sensitive measure in response to 
changes in PD severity but it is unclear what impact dentition has on this measure.  
 
The TOMASS raw data measures were positively correlated with TWST measures and EAT-
10 scores indicating that the TOMASS is a solid food correlate to the TWST as intended and 
there is a relationship between decreased efficiency in completing the TOMASS and the 
presence of dysphagia. Further research to validate the TOMASS is required before strong 
conclusions can be drawn on its clinical application. 
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Chapter 6. Appendix 
 
 
Table 6-1 – Descriptive statistics for participant age and sex for each group 
Group Sex of participant Age of participant in years 
Male Female mean median Standard 
deviation 
Range 
N % N % 
All control participants (n = 26) 19 73 7 27 70 70 9.86 46-85 
All PD participants (n = 40) 30 75 10 25 70.15 72.00 8.52 48-86 
Control for mild-moderate PD (n = 20) 14 70 6 30 67.40 69.50 9.31 46-80 
Mild-moderate PD (n = 20) 14 70 6 30 66.75 69.00 9.37 48-79 
Control for advanced PD (n = 20) 16 80 4 20 73.30 72.50 6.67 62-85 
Advanced PD (n = 20) 16 80 4 20 73.55 74.50 6.07 62-86 
 
 
Figure 6-1 - Bar graph representing the mean age of participants between the PD groups and their 
respective control groups. 
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Table 6-2 - Descriptive statistics for years since PD diagnosis 
 No. of years since formal PD diagnosis  
Group  Range Mean Median Standard deviation 
Mild-moderate PD (N = 20) 2 - 20 8.40 6.50 5.605 
Advanced PD (N = 19) 5 - 35 16.47 15.00 8.161 
 
 
Figure 6-2 - Box and whisker plot representing range and median MDS-UPDRS scores of PD groups 
 
 
 
Table 6-3 – Descriptive statistics comparing Hoehn and Yahr and MDS-UPDRS scores across groups 
 Hoehn and Yahr MDS-UPDRS score 
Group (N 
= 20) 
Score Frequency Percentage Mean Standard 
deviation 
Range Mean Median Standard 
deviation 
Mild-
moderate 
PD 
2 11 55 2.325 .406 13 - 54 
 
36.80 
 
36.00 
 
11.40 
 2.5 5 25 
3 4 20 
Advanced 
PD 
4 18 90 4.05 .394 50 - 94 66.20 65.50 10.90 
5 2 10 
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Table 6-4 – Descriptive statistics comparing EAT-10 scores between groups 
 EAT-10 score 
Group (N = 20) Range Mean Standard deviation Percentage of scores ≤ 3 
Control for mild-moderate PD 0 - 4 0.60 1.14 95 
Mild-moderate PD 0 - 21 4.80 5.25 45 
Control for advanced PD 0 - 4 0.60 1.14 95 
Advanced PD 0 - 22 6.75 5.79 25 
Scores higher than three indicate the presence of dysphagia (Belafsky et al., 2008). 
 
 
Figure 6-3 - Box and whisker plot representing the median and range of EAT-10 scores between groups 
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Figure 6-4 - Bar graphs representing group means for each TOMASS raw data variable 
  
  
 
 
Figure 6-5 - Box and whisker plot representing distribution of time taken in seconds for the TOMASS 
across groups 
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Figure 6-7 - Box and whisker plot representing distribution of Number of Masticatory Cycles for the 
TOMASS across groups 
 
Figure 6-6 Box and whisker plot representing distribution of number of swallows for the TOMASS 
across groups 
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Figure 6-8 - Box and whisker plot representing distribution of Number of Bites for the TOMASS across 
groups 
 
 
 
 
 
 
Figure 6-9 - Bar graphs representing group means for each TWST calculated measure variable 
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Figure 6-10 - Box and whisker plot representing distribution of Volume per Swallow for the TWST 
across groups 
Figure 6-11 - Box and whisker plot representing distribution of Volume per Time for the TWST 
across groups 
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Figure 6-12 - Box and whisker plot representing distribution of Time per Swallow for the TWST 
across groups 
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Figure 6-13 - Scatter plots representing the relationship between comparable TWST and TOMASS 
variables 
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Figure 6-14 - Scatter plots representing the relationship between comparable total EAT-10 score 
and TOMASS variables 
